ALB and cancer: 149Tb as well as its three others isotopes of interest 152Tb for PET, 155Tb for SPECT and 161Tb for therapy with low energy α particles, were the object of an interesting investigation in which a new construct (cm09) was developed including a DOTA as chelating moiety, associated to folic acid as vector for targeting folate receptor-positive cancer cells (involved in many types of cancers such as breast, colorectal, renal or ovarian cancer) and to 4-(p-iodophenyl) butyric acid, to enhance affinity with human serum albumin for extending the blood half-life of the conjugate [279].